Vis enkel innførsel

dc.contributor.authorThorsen, Lene
dc.contributor.authorCourneya, Kerry S.
dc.contributor.authorSteene-Johannessen, Jostein
dc.contributor.authorGran, Jon Michael
dc.contributor.authorHaugnes, Hege Sagstuen
dc.contributor.authorNegaard, Helene Francisca Stigter
dc.contributor.authorKiserud, Cecilie E.
dc.contributor.authorFosså, Sophie Dorothea
dc.date.accessioned2023-10-12T12:43:18Z
dc.date.available2023-10-12T12:43:18Z
dc.date.created2023-06-29T10:48:31Z
dc.date.issued2023
dc.identifier.citationInternational Journal of Cancer. 2023, 153(8), Side 1512-1519.en_US
dc.identifier.issn0020-7136
dc.identifier.urihttps://hdl.handle.net/11250/3096138
dc.descriptionThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_US
dc.description.abstractPhysical activity (PA) has been associated with reduced mortality among cancer survivors, but no study has focused on testicular cancer survivors (TCSs). We aimed to investigate the association of PA measured twice during survivorship with overall mortality in TCSs. TCSs treated during 1980 to 1994 participated in a nationwide longitudinal survey between 1998 to 2002 (S1: n = 1392) and 2007 to 2009 (S2: n = 1011). PA was self-reported by asking for the average hours per week of leisure-time PA in the past year. Responses were converted into metabolic equivalent task hours/week (MET-h/wk) and participants were categorized into: Inactives (0 MET-h/wk), Low-Actives (2-6 MET-h/wk), Actives (10-18 MET-h/wk) and High-Actives (20-48 MET-h/wk). Mortality from S1 and S2, respectively, was analyzed using the Kaplan-Meier estimator and Cox proportional hazards models until the End of Study (December 31, 2020). Mean age at S1 was 45 years (SD 10.2). Nineteen percent (n = 268) of TCSs died between S1 and EoS, with 138 dying after S2. Compared to Inactives at S1, the mortality risk among Actives was 51% lower (HR 0.49, 95% CI: 0.29-0.84) with no further mortality reduction among High-Actives. At S2, the mortality risk was at least 60% lower among the Actives, High-Actives and even the Low-Actives compared to the Inactives. Persistent Actives (≥10 MET-h/wk at S1 and S2) had a 51% lower mortality risk compared to Persistent Inactives (<10 MET-h/wk at S1 and S2; HR 0.49, 95% CI: 0.30-0.82). During long-term survivorship after TC treatment, regular and maintained PA were associated with an overall mortality risk reduction of at least 50%.en_US
dc.language.isoengen_US
dc.subjectlong-term testicular cancer survivorsen_US
dc.subjectoverall mortalityen_US
dc.subjectphysical activityen_US
dc.titleAssociation of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal studyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2023 The Authorsen_US
dc.source.pagenumber1512-1519en_US
dc.source.volume153en_US
dc.source.journalInternational Journal of Canceren_US
dc.source.issue8en_US
dc.identifier.doi10.1002/ijc.34625
dc.identifier.cristin2159364
dc.description.localcodeInstitutt for idrettsmedisinske fag / Department of Sports Medicineen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel